ENTELLUS MEDICAL INC Interest Expense
ENTELLUS MEDICAL INC reported Interest Expense of $1.02 million for the 3-month period ending 2017-09-30, per its 10-Q filed 2017-11-03.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2017-11-03
- ENTELLUS MEDICAL INC interest expense for the quarter ending 2017-09-30 was $1.02M, a 81.14% increase year-over-year.
- ENTELLUS MEDICAL INC interest expense for the quarter ending 2017-06-30 was $446.00K, a 20.64% decline year-over-year.
- ENTELLUS MEDICAL INC interest expense for the quarter ending 2017-03-31 was $565.00K, a 0.53% increase year-over-year.
- ENTELLUS MEDICAL INC interest expense for the quarter ending 2016-12-31 was $562.00K, a 0.00% change year-over-year.
- ENTELLUS MEDICAL INC interest expense for fiscal 2016 was $2.25M, a 13.67% decline from fiscal 2015.
- ENTELLUS MEDICAL INC interest expense for fiscal 2015 was $2.60M, a 36.76% increase from fiscal 2014.
- ENTELLUS MEDICAL INC interest expense for fiscal 2014 was $1.90M, a 75.97% increase from fiscal 2013.
- ENTELLUS MEDICAL INC interest expense for fiscal 2013 was $1.08M.
| Period end | Interest Expense 3 month | Interest Expense 3 month as first filed | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|---|
| 2017-09-30 | $1.02M 10-Q · filed 2017-11-03 | $1.46M derived: sum of 2 quarters · filed 2017-11-03 | $2.03M 10-Q · filed 2017-11-03 | $2.59M derived: sum of 4 quarters · filed 2017-11-03 | |
| 2017-06-30 | $446.00K 10-Q · filed 2017-08-04 | $1.01M 10-Q · filed 2017-08-04 | $1.57M derived: sum of 3 quarters · filed 2017-08-04 | $2.13M derived: sum of 4 quarters · filed 2017-11-03 | |
| 2017-03-31 | $565.00K 10-Q · filed 2017-05-05 | $1.13M derived: sum of 2 quarters · filed 2017-05-05 | $1.69M derived: sum of 3 quarters · filed 2017-11-03 | $2.25M derived: sum of 4 quarters · filed 2017-11-03 | |
| 2016-12-31 | $562.00K 10-K · filed 2017-02-22 | $1.12M derived: sum of 2 quarters · filed 2017-11-03 | $1.69M derived: sum of 3 quarters · filed 2017-11-03 | $2.25M 10-K · filed 2017-02-22 | |
| 2016-09-30 | $562.00K 10-Q · filed 2017-11-03 | $1.12M derived: sum of 2 quarters · filed 2017-11-03 | $1.69M 10-Q · filed 2017-11-03 | $2.25M derived: sum of 4 quarters · filed 2017-11-03 | |
| 2016-06-30 | $562.00K 10-Q · filed 2017-08-04 | $1.12M 10-Q · filed 2017-08-04 | $1.69M derived: sum of 3 quarters · filed 2017-08-04 | $2.25M derived: sum of 4 quarters · filed 2017-08-04 | |
| 2016-03-31 | $562.00K 10-Q · filed 2017-05-05 | $1.12M derived: sum of 2 quarters · filed 2017-05-05 | $1.69M derived: sum of 3 quarters · filed 2017-05-05 | $2.25M derived: sum of 4 quarters · filed 2017-05-05 | |
| 2015-12-31 | $562.00K 10-K · filed 2017-02-22 | $1.12M derived: sum of 2 quarters · filed 2017-02-22 | $1.69M derived: sum of 3 quarters · filed 2017-02-22 | $2.60M 10-K · filed 2017-02-22 | |
| 2015-09-30 | $561.00K 10-K · filed 2017-02-22 | $1.12M derived: sum of 2 quarters · filed 2017-02-22 | $2.04M 10-Q · filed 2016-11-04 | $2.53M derived: sum of 4 quarters · filed 2017-02-22 | |
| 2015-06-30 | $562.00K 10-K · filed 2017-02-22 | $1.48M 10-Q · filed 2016-08-04 | $1.97M derived: sum of 3 quarters · filed 2017-02-22 | $2.44M derived: sum of 4 quarters · filed 2017-02-22 | |
| 2015-03-31 | $919.00K 10-K · filed 2017-02-22 | $1.41M derived: sum of 2 quarters · filed 2017-02-22 | $1.88M derived: sum of 3 quarters · filed 2017-02-22 | $2.40M derived: sum of 4 quarters · filed 2017-02-22 | |
| 2014-12-31 | $487.00K 10-K · filed 2016-02-25 | $960.00K derived: sum of 2 quarters · filed 2016-02-25 | $1.48M derived: sum of 3 quarters · filed 2016-02-25 | $1.90M 10-K · filed 2017-02-22 | |
| 2014-09-30 | $473.00K 10-K · filed 2016-02-25 | $474.00K 10-Q · filed 2015-11-06 | $996.00K derived: sum of 2 quarters · filed 2016-02-25 | $1.42M 10-Q · filed 2015-11-06 | |
| 2014-06-30 | $523.00K 10-K · filed 2016-02-25 | $944.00K 10-Q · filed 2015-08-07 | |||
| 2014-03-31 | $421.00K 10-K · filed 2016-02-25 | ||||
| 2013-12-31 | $1.08M 10-K · filed 2016-02-25 |